Relay Therapeutics, Inc. (RLAY) Total liabilities 2020–2025
Relay Therapeutics, Inc. (RLAY) total liabilities at each fiscal year-end, per SEC filings.
$54.3MFY2025 · since FY2020: $36.5M → $54.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.3M | -42.0% |
| FY2024 | $93.5M | +1.7% |
| FY2023 | $92.0M | -38.5% |
| FY2022 | $149.6M | +35.2% |
| FY2021 | $110.6M | +202.8% |
| FY2020 | $36.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice